Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team… JUPITER, Fla., March 26, 2026 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGN...
Ligand Pharmaceuticals (LGND) stock jumps premarket as BofA starts its coverage with a Buy rating and a $244 target, citing its business model. Read more here. Ligand gains new Buy from BofA on high-m...
